Human Oncology Multi-Gene Mutations Detection Kit (NGS)

Product Description

Human Oncology Multi-Gene Mutations Detection Kit
High-Throughput Sequencing

 
Gene Mutation and Tumor
Human cells contain DNA (except red blood cells), which constitute approximately *0,**0 to *5,**0 genes, the gene mutation  inside of people is generally divided into two ways, random mutations and genetic mutations, which are slowly accumulated by the mutation of harmful genes, and a key gene will eventually mutate that triggers the tumor.
Targeted drugs are able to target the pathological molecules caused by specific gene mutations, improve drug efficacy, reduce side effects. Therefore, through genetic testing to understand whether to carry a specific gene mutation, is a key indicator to determine whether or not that we can benefit from targeted drug treatment.
Advantages and Characteristics
Easy operation: With independent patented RingCap™ technology, library construction can be done in two steps.
Rapid Detection: Library construction takes only 3.5 hours, and it takes only 2 working days from sample extraction to report completing.
High sensitivity:With *0,**0 ⨯sequencing depth, up to 0.1% sensitivity ,this kit achieves drug resistance monitoring of the liquid biopsy samples.
Comprehensive Inspection: As one targeted drug recommended by both the domestic and the foreign authorities, this kit can detect *3 mutant genes, **9 existing targeted drug-related COSMIC locus in one time, and it can make a comprehensive analysis of non-small cell lung cancer and colorectal cancer.